Home/Filings/4/0001562180-25-002161
4//SEC Filing

Puri Michal Nath 4

Accession 0001562180-25-002161

CIK 0001645113other

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 4:41 PM ET

Size

7.5 KB

Accession

0001562180-25-002161

Insider Transaction Report

Form 4
Period: 2025-03-04
Puri Michal Nath
Chief Human Resources Officer
Transactions
  • Award

    Ordinary Shares

    2025-03-04$18.19/sh+54,975$999,995163,681 total
  • Award

    Stock Options (Right to buy)

    2025-03-04$18.19/sh+81,499$1,482,46781,499 total
    Exercise: $18.19From: 2026-03-04Exp: 2035-03-03Ordinary Shares (81,499 underlying)
Footnotes (2)
  • [F1]Represents restricted share units that are scheduled to vest in equal installments on March 4, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.
  • [F2]Options to buy 81,499 ordinary shares will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the reporting person's continued employment through such dates.

Issuer

NovoCure Ltd

CIK 0001645113

Entity typeother

Related Parties

1
  • filerCIK 0001997032

Filing Metadata

Form type
4
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:41 PM ET
Size
7.5 KB